About Tarsus Pharmaceuticals Inc
- Industry: Pharmaceuticals
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.tarsusrx.com/
Frequently Asked Questions
What is the 52-week range for TARS?
The 52-week high is $91.53 and the 52-week low is $53.89.
What is the P/E ratio for TARS?
The P/E ratio data is currently unavailable.
What is the dividend yield for TARS?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -13.53%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -7.67%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 10.12.
Analyst Recommendation Trends
Wall Street analyst consensus for TARS over the last few months:
Latest TARS News
Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting
IRVINE, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) today announced that it expects to present 11 scientific abstracts at the American Academy of Optometry (AAOpt) 2026 Annual Meeting, taking place Sept. 30–Oct. 3 in Anaheim, California. The planned abstracts provide new insights into the patient burden, diagnosis and treatment of Demodex blepharitis (DB); real-world experiences and outcomes with XDEMVY® (lotilaner ophthalmic solution) 0.25%; and the pr
Goldman Sachs Reinstates Buy on Tarsus Pharmaceuticals, Announces $116 Price Target
Goldman Sachs analyst Andrea Newkirk reinstates Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and announces $116 price target.
When To Dump Stocks: These IBD 50 Components Hit Sell Signals
Investor's Business Daily's IBD 50 index is on track for a third straight down month, and some of its components are sputtering. Various factors help decide when to sell stocks, and five have already triggered sell signals. AngloGold Ashanti broke out above a 113.30 buy point on Aug. 20.
Barclays Reinstates Overweight on Tarsus Pharmaceuticals, Announces $110 Price Target
Barclays analyst Glen Santangelo reinstates Tarsus Pharmaceuticals (NASDAQ:TARS) with a Overweight and announces $110 price target.
Jefferies Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $105
Jefferies analyst Anthony Petrone maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and raises the price target from $88 to $105.
Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care
Adds gildeuretinol (ALK-001), a differentiated Phase 3 oral investigational medicine designed to target the underlying biology of Stargardt’s disease, a potentially blinding disease with no FDA-approved therapy Strengthens Tarsus’ differentiated pipeline and leadership in eye care IRVINE, Calif., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) today announced that it has completed its previously announced acquisition of Alkeus Pharmaceuticals, Inc., a privately hel
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-15 | LINK WILLIAM J PHD | -201 | - | - |
| 2026-09-15 | LINK WILLIAM J PHD | -66 | $80.01 | $5,281 |
| 2026-09-15 | LINK WILLIAM J PHD | -759 | $79 | $59,961 |
| 2026-09-15 | LINK WILLIAM J PHD | -11,675 | $78.33 | $914,503 |
| 2026-09-15 | LINK WILLIAM J PHD | +201 | - | - |
| 2026-09-15 | YARNO WENDY L | -302 | - | - |
| 2026-09-15 | YARNO WENDY L | +302 | - | - |
| 2026-09-15 | PYOTT DAVID E I | -201 | - | - |
| 2026-09-15 | PYOTT DAVID E I | +201 | - | - |
| 2026-09-04 | Lin Elizabeth Yeu | -1,590 | $90 | $143,100 |
| 2026-09-04 | Lin Elizabeth Yeu | -1,590 | $85 | $135,150 |
| 2026-09-04 | Lin Elizabeth Yeu | -5,386 | $90 | $484,740 |
| 2026-09-04 | Lin Elizabeth Yeu | -5,387 | $85 | $457,895 |
| 2026-09-04 | Azamian Bobak R. | -2,900 | $91.27 | $264,683 |
| 2026-09-04 | Azamian Bobak R. | -7,100 | $90.27 | $640,917 |
| 2026-09-04 | Neervannan Seshadri | -4,564 | $85 | $387,940 |
| 2026-09-02 | Lin Elizabeth Yeu | -1,590 | $80 | $127,200 |
| 2026-09-02 | Lin Elizabeth Yeu | -5,387 | $80 | $430,960 |
| 2026-09-02 | Azamian Bobak R. | -10,000 | $80.06 | $800,600 |
| 2026-09-01 | Lin Elizabeth Yeu | -4,601 | $73.86 | $339,830 |
| 2026-06-17 | Azamian Bobak R. | -5,418 | $61.81 | $334,887 |
| 2026-06-17 | Azamian Bobak R. | -4,582 | $61.24 | $280,602 |
| 2026-06-16 | Farrow Jeffrey S | -14,396 | $60.95 | $877,436 |
| 2026-06-15 | Farrow Jeffrey S | -27,881 | - | - |
| 2026-06-15 | Farrow Jeffrey S | +27,881 | - | - |
| 2026-06-15 | LINK WILLIAM J PHD | -1,928 | $62.94 | $121,348 |
| 2026-06-15 | LINK WILLIAM J PHD | -10,572 | $61.97 | $655,147 |
| 2026-06-12 | Goodrich Katherine | -2,954 | - | - |
| 2026-06-12 | Goodrich Katherine | +2,954 | - | - |
| 2026-06-12 | Goldberg Andrew D. | -2,954 | - | - |
| 2026-06-12 | Goldberg Andrew D. | +2,954 | - | - |
| 2026-06-12 | Morrison Scott W | -2,954 | - | - |
| 2026-06-12 | Morrison Scott W | +2,954 | - | - |
| 2026-06-12 | CHAUDHURI BHASKAR | -2,954 | - | - |
| 2026-06-12 | CHAUDHURI BHASKAR | +2,954 | - | - |
| 2026-06-12 | LINK WILLIAM J PHD | -2,954 | - | - |
| 2026-06-12 | LINK WILLIAM J PHD | +2,954 | - | - |
| 2026-06-12 | YARNO WENDY L | -2,954 | - | - |
| 2026-06-12 | YARNO WENDY L | +2,954 | - | - |
| 2026-04-24 | PYOTT DAVID E I | -1,383 | - | - |
| 2026-04-24 | PYOTT DAVID E I | +1,383 | - | - |
| 2026-03-20 | Neervannan Seshadri | -2,989 | $66.75 | $199,516 |
| 2026-03-19 | Lin Elizabeth Yeu | -390 | $67 | $26,130 |
| 2026-03-19 | Wahl Bryan | -4,231 | $67 | $283,477 |
| 2026-03-19 | Whitfield Dianne C. | -4,174 | $67 | $279,658 |
| 2026-03-19 | Azamian Bobak R. | -11,964 | $67 | $801,588 |
| 2026-03-19 | Neervannan Seshadri | -4,589 | $67 | $307,463 |
| 2026-03-19 | Mottiwala Aziz | -4,440 | $67 | $297,480 |
| 2026-03-19 | Farrow Jeffrey S | -2,186 | $67 | $146,462 |
| 2026-03-18 | Lin Elizabeth Yeu | -379 | $68.71 | $26,041 |
| 2026-03-18 | Wahl Bryan | -4,125 | $68.71 | $283,429 |
| 2026-03-18 | Whitfield Dianne C. | -4,071 | $68.71 | $279,718 |
| 2026-03-18 | Azamian Bobak R. | -11,667 | $68.71 | $801,640 |
| 2026-03-18 | Neervannan Seshadri | -3,610 | $68.71 | $248,043 |
| 2026-03-18 | Mottiwala Aziz | -4,330 | $68.71 | $297,514 |
| 2026-03-18 | Farrow Jeffrey S | -2,133 | $68.71 | $146,558 |
| 2026-03-17 | Lin Elizabeth Yeu | -375 | $69.42 | $26,033 |
| 2026-03-17 | Wahl Bryan | -4,084 | $69.42 | $283,511 |
| 2026-03-17 | Whitfield Dianne C. | -4,029 | $69.42 | $279,693 |
| 2026-03-17 | Azamian Bobak R. | -10,972 | $69.42 | $761,676 |
| 2026-03-17 | Neervannan Seshadri | -3,125 | $69.42 | $216,938 |
| 2026-03-17 | Mottiwala Aziz | -4,286 | $69.42 | $297,534 |
| 2026-03-17 | Farrow Jeffrey S | -2,111 | $69.42 | $146,546 |
| 2026-03-16 | LINK WILLIAM J PHD | -493 | $69.75 | $34,387 |
| 2026-03-16 | LINK WILLIAM J PHD | -8,378 | $69.03 | $578,333 |
| 2026-03-16 | LINK WILLIAM J PHD | -3,629 | $68.09 | $247,099 |
| 2026-03-15 | Lin Elizabeth Yeu | -2,511 | - | - |
| 2026-03-15 | Lin Elizabeth Yeu | +2,511 | - | - |
| 2026-03-15 | Wahl Bryan | -5,022 | - | - |
| 2026-03-15 | Wahl Bryan | -7,176 | - | - |
| 2026-03-15 | Wahl Bryan | -7,248 | - | - |
| 2026-03-15 | Wahl Bryan | -4,790 | - | - |
| 2026-03-15 | Wahl Bryan | +24,236 | - | - |
| 2026-03-15 | Whitfield Dianne C. | -5,022 | - | - |
| 2026-03-15 | Whitfield Dianne C. | -7,176 | - | - |
| 2026-03-15 | Whitfield Dianne C. | -7,248 | - | - |
| 2026-03-15 | Whitfield Dianne C. | -4,463 | - | - |
| 2026-03-15 | Whitfield Dianne C. | +23,909 | - | - |
| 2026-03-15 | Azamian Bobak R. | -14,878 | - | - |
| 2026-03-15 | Azamian Bobak R. | -23,121 | - | - |
| 2026-03-15 | Azamian Bobak R. | -16,975 | - | - |
| 2026-03-15 | Azamian Bobak R. | -11,300 | - | - |
| 2026-03-15 | Azamian Bobak R. | +66,274 | - | - |
| 2026-03-15 | Neervannan Seshadri | -5,022 | - | - |
| 2026-03-15 | Neervannan Seshadri | -8,020 | - | - |
| 2026-03-15 | Neervannan Seshadri | -8,148 | - | - |
| 2026-03-15 | Neervannan Seshadri | -5,097 | - | - |
| 2026-03-15 | Neervannan Seshadri | +26,287 | - | - |
| 2026-03-15 | Mottiwala Aziz | -5,524 | - | - |
| 2026-03-15 | Mottiwala Aziz | -8,020 | - | - |
| 2026-03-15 | Mottiwala Aziz | -8,148 | - | - |
| 2026-03-15 | Mottiwala Aziz | -4,790 | - | - |
| 2026-03-15 | Mottiwala Aziz | +26,482 | - | - |
| 2026-03-15 | Farrow Jeffrey S | -5,022 | - | - |
| 2026-03-15 | Farrow Jeffrey S | -8,020 | - | - |
| 2026-03-15 | Farrow Jeffrey S | +13,042 | - | - |
| 2026-03-05 | Lin Elizabeth Yeu | +17,161 | - | - |
| 2026-03-05 | Lin Elizabeth Yeu | +27,310 | - | - |
| 2026-03-05 | Wahl Bryan | +17,161 | - | - |
| 2026-03-05 | Wahl Bryan | +27,310 | - | - |
| 2026-03-05 | Whitfield Dianne C. | +17,161 | - | - |
| 2026-03-05 | Whitfield Dianne C. | +27,310 | - | - |
| 2026-03-05 | Azamian Bobak R. | +60,776 | - | - |
| 2026-03-05 | Azamian Bobak R. | +96,723 | - | - |
| 2026-03-05 | Neervannan Seshadri | +17,161 | - | - |
| 2026-03-05 | Neervannan Seshadri | +27,310 | - | - |
| 2026-03-05 | Mottiwala Aziz | +19,306 | - | - |
| 2026-03-05 | Mottiwala Aziz | +30,724 | - | - |
| 2026-03-05 | Farrow Jeffrey S | +19,306 | - | - |
| 2026-03-05 | Farrow Jeffrey S | +30,724 | - | - |
| 2026-03-04 | Neervannan Seshadri | -8,366 | $76.67 | $641,421 |
| 2026-02-18 | PYOTT DAVID E I | +3,729 | - | - |
| 2026-02-18 | PYOTT DAVID E I | +5,893 | - | - |
| 2026-01-02 | Whitfield Dianne C. | -893 | $82.93 | $74,056 |
| 2026-01-02 | Whitfield Dianne C. | -835 | $81.9 | $68,387 |
| 2026-01-02 | Whitfield Dianne C. | -8,122 | $80.71 | $655,527 |
| 2026-01-02 | Whitfield Dianne C. | -5,715 | $80.09 | $457,714 |
| 2025-12-24 | Azamian Bobak R. | -557 | $83.54 | $46,532 |
| 2025-12-24 | Azamian Bobak R. | -5,443 | $82.41 | $448,558 |
| 2025-12-16 | Whitfield Dianne C. | -7,397 | $80.1 | $592,500 |
| 2025-12-16 | Neervannan Seshadri | +475 | - | - |
| 2025-12-16 | Neervannan Seshadri | -950 | - | - |
| 2025-12-16 | Lin Elizabeth Yeu | -2,078 | $79.5 | $165,201 |
| 2025-12-15 | Goodrich Katherine | -2,233 | - | - |
| 2025-12-15 | Goodrich Katherine | +2,233 | - | - |
| 2025-12-15 | Lin Elizabeth Yeu | -6,819 | - | - |
| 2025-12-15 | Lin Elizabeth Yeu | +6,819 | - | - |
| 2025-12-15 | LINK WILLIAM J PHD | -4,766 | $81.5 | $388,429 |
| 2025-12-15 | LINK WILLIAM J PHD | -5,680 | $80.71 | $458,433 |
| 2025-12-15 | LINK WILLIAM J PHD | -1,148 | $82.39 | $94,584 |
| 2025-12-15 | LINK WILLIAM J PHD | -6,306 | $81.75 | $515,516 |
| 2025-12-15 | LINK WILLIAM J PHD | -5,046 | $80.8 | $407,717 |
| 2025-12-04 | Azamian Bobak R. | -51,885 | - | - |